AvidinOx-Lu-177-DOTA-Biotin

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameAvidinOx-Lu-177-DOTA-Biotin
Drug Alias NameST-2210[177Lu]DOTA-biotin177Lu-ST-2210
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIonising radiation emitters
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyAustria
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSigma-Tau Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlfasigma Spa
Active IndicationsN/A
Inactive IndicationsSolid tumoursLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A